HCR.20.058 – Vitality Monitoring at Home for Proactive Personalized Positive Health Management
Multimorbidity is a growing social and economic healthcare burden internationally leading to functional decline and in the long term to inability to live independently. Biopsychosocial factors are known to play an important role in the identification and treatment of this functional decline. Assessment of early signs of changes in this biopsychosocial status is therefore of utmost importance to prevent or delay future hospitalization and worsening of the individual’s quality of life. It is our social challenge/duty to (1) identify the individuals at risk, (2) monitor physical, cognitive and contextual status and (3) prevent hospitalization by targeted treatment on physical, mental and social domains in order to maintain or improve self-reliance, participation and to reduce the burden on informal caregivers. By using available formal and informal knowledge (identification), monitor by means of innovative physical biomarking based on available wearable techniques for timely and targeted treatment we propose to reduce the economic and social burden on the institutionalized and informal care. We aim to prolong living at home with an optimal quality of life: 1)IDENTIFICATION: contacts of individuals such as care-givers, family and health care practitioners are known to recognize patients at risk for functional decline. In this project we recruit these ‘knowledge brokers’ out of the environment of the patient to identify multi-morbid individuals at risk; 2) MONITORING: Applying expert signal analysis from available wearables will result in biomarkers that account for the physical, cognitive and social resilience of the multi-morbid target group; 3) TREATMENT: functional diagnostics applied after monitoring lead to personalized physical, cognitive, social and/or behavioral interventions in the home-environment. The combination of Identification, Monitoring and Treatment should improve the physical, mental and social vitality, self-reliance and participation of the multimorbid target group and consequently reduce the social and economic burden.
Ambulant Monitoring, Biomarker, Biopsychosocial Model, multimorbidity, Personalized medicine, Value Based Health Care
|Organisation||Dept of Rehabilitation, LUMC (LUMC)|
|Name||Dr. Sven K. Schiemanck|